Detalhe da pesquisa
1.
Treatment-related pneumonitis after thoracic radiotherapy/chemoradiotherapy combined with anti-PD-1 monoclonal antibodies in advanced esophageal squamous cell carcinoma.
Strahlenther Onkol
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267589
2.
Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
BMC Gastroenterol
; 24(1): 156, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720257
3.
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
Ann Surg
; 277(2): 259-266, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605586
4.
Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases.
BMC Cancer
; 23(1): 1240, 2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104068
5.
Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
BMC Cancer
; 23(1): 681, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474893
6.
Effects of PEG in patients with esophageal squamous cell carcinoma during concurrent chemoradiotherapy: a prospective study.
Gastrointest Endosc
; 98(6): 901-910.e3, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150411
7.
Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
Ann Surg
; 274(6): e1022-e1029, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31855875
8.
Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.
Oncologist
; 26(7): e1110-e1124, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893689
9.
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey.
Acta Oncol
; 60(5): 627-634, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793382
10.
Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study.
Oncologist
; 25(10): e1464-e1472, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342599
11.
Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
BMC Cancer
; 20(1): 837, 2020 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883221
12.
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
BMC Cancer
; 20(1): 36, 2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941487
13.
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
BMC Cancer
; 20(1): 194, 2020 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32143580
14.
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
BMC Cancer
; 19(1): 492, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31122185
15.
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
BMC Cancer
; 19(1): 397, 2019 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036088
16.
Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
BMC Cancer
; 23(1): 697, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491217
17.
Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
Cancer Sci
; 108(4): 590-597, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192623
18.
High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.
Tumour Biol
; 37(10): 13489-13498, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465554
19.
XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
Cancer Sci
; 106(12): 1678-86, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383967
20.
The impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancer.
Tumour Biol
; 36(6): 4617-25, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623115